InSight buys two Boston area centers
The weakest are always the most vulnerable in a crisis, a tenet that may currently apply to emerging markets for medical imaging equipment. Revenues from CT and MR scanner sales in Russia, Brazil, and India are expected to shrink by almost 15% this year, according to market analysis firm Millennium Research Group.
Brazil and India are at particular risk, because the global economic downturn forced a significant devaluation of Brazilian and Indian currencies during the first four months of 2009. This action, in turn, has increased the relative cost of imported diagnostic imaging systems from U.S. and European vendors. The higher pricing has made acquiring imported scanners difficult for facilities. As a result, growth in the Brazilian and Indian diagnostic imaging system markets will be severely limited in 2009. In Russia, falling demand for crude oil and a resulting drop in revenues has affected the country's economy, while mounting political unrest has increased uncertainty.
InSight Health Services has completed the purchase of two imaging centers in the Boston metropolitan area. One provides MR exclusively; the other is a multimodality provider. The two centers expand the presence of Lake Forest, CA-based InSight's presence in its New England regional market, which stretches from Maine to Connecticut. InSight provides diagnostic services in more than 30 states through more than 60 fixed-site centers and more than 100 mobile assets.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).